Output Explorer

Every prompt in the paper, and what each model wrote back.

Return exactly ten single-sentence facts as JSON. Quality was judged pairwise; here you see the raw outputs and whether the JSON parsed.

13 of 1,000 prompts

FORR · Q1 20262026-05-06 FCF · Q1 20262026-04-29 KWR · Q4 20252026-02-24 CSBR · Q3 20262026-03-12 SMTI · Q4 20252026-03-24 OKE · Q2 20252025-08-05 NPCE · Q4 20252026-03-03 LOCO · Q4 20252026-03-12 SNX · Q4 20252026-01-08 BSET · Q1 20262026-04-02 TRC · Q4 20252026-03-19 WLFC · Q4 20252026-03-10 RMNI · Q3 20252025-10-30

Nearby prompts. All 1,000 Earnings calls prompts

PromptNPCE· Q4 2025 · call on2026-03-03· transcript 48,147 characters

Analyze the following earnings call transcript and extract the 10 most investor-relevant facts.

Each fact must:
- Be drawn only from the transcript (do not use any outside information).
- Be a single sentence capturing a specific, quantified insight relevant to investors.
- Avoid regurgitating the transcript verbatim; instead, synthesize and distill the information into investor-relevant facts.

Return only a JSON object with this exact structure (no markdown fences, no commentary):
{"facts": ["<fact 1>", "<fact 2>", ..., "<fact 10>"]}

The list must contain exactly 10 facts.

Transcript:
<transcript>
transcript redacted — the source calls are not publicly licensed
</transcript>

System prompt · identical for every setup

You are a financial analyst. You extract the most investor-relevant facts from earnings call transcripts to help investors anticipate the stock's reaction to the call.

Reference

No reference summary is published. Quality was judged pairwise by a separate model and is reported in aggregate on the main page.

Ours

10 facts · valid JSON

Fourth quarter 2025 total revenue reached $26.6 million, representing a 24% year-over-year increase driven primarily by a 26% growth in core RNS system sales.
The company achieved positive adjusted EBITDA of $900,000 in the fourth quarter, marking the second consecutive quarter of positive results and positive operating cash flow of approximately $500,000.
Management reiterated full-year 2026 revenue guidance of $98 million to $100 million on a continuing operations basis, which excludes any contribution from the pending idiopathic generalized epilepsy (IGE) indication or DIXI Medical operations.
Gross margin improved to 77.4% in the fourth quarter, with the core RNS system specifically achieving a gross margin of 80.5% due to manufacturing efficiencies and favorable pricing.
The company formally submitted a PMA supplement to the FDA on December 15, 2025, seeking an expanded indication for IGE supported by NAUTILUS study data showing a 77% reduction in median seizure rates over 18 months.
Operating expenses in the fourth quarter grew only 13% to $22.3 million, demonstrating operating leverage by remaining significantly below the 24% revenue growth rate.
The company generated approximately $400,000 in free cash flow during the fourth quarter while ending the period with $61.1 million in cash, cash equivalents, and short-term investments.
For 2026, the company plans to invest deliberately in its commercial organization with non-GAAP sales and marketing expenses budgeted between $46 million and $48 million to scale the business.
The Seizure ID AI tool, designed to automate the identification of seizure trends to improve physician workflow, is paired with a cloud migration and is expected to receive regulatory approval in the first half of 2026.
The company is transitioning DIXI Medical results to discontinued operations beginning in Q1 2026, as the commercial partnership concluded on December 31, 2025, and remaining inventory was sold back to the partner.

Aux 2015

Invalid JSONshown as written

Facts:

Revenue Growth: $26.6 million in Q4 2025, representing 24% year-over-year growth.
RNS System Revenue: $22.4 million, up 26% year-over-year.
Community Access: Expanded referral pathways and site engagement contributed to 26% growth in RNS System revenue.
Patient Pipeline: 24% year-over-year growth in prescribers, accounts, and patient pipeline.
Gross Margin: 77.4% in Q4 2025, up from 75.4% in Q4 2024.
Adjusted EBITDA: $900,000 in Q4 2025, a $1.9 million improvement over Q4 2024.
Operating Expense: $22.3 million in Q4 2025, down from $19.8 million in Q4 2024.
Stock-Based Compensation: Included in operating expenses for Q4 2025.
Depreciation & Amortization: Not included.
Adjusted EBITDA (Non-GAAP): $900,000 in Q4 2025, a $1.9 million improvement over Q4 2024.

Key Insights:

Revenue Growth: 24% year-over-year, driven by strong RNS System adoption and expanded community access.
Gross Margin: 77.4% in Q4 2025, up from 75.4% in Q4 2024.
Adjusted EBITDA: $900,000 in Q4 2025, a $1.9 million improvement over Q4 2024.
Operating Expense: $22.3 million in Q4 2025, down from $19.8 million in Q4 2024.
Stock-Based Compensation: Included in operating expenses.
Adjusted EBITDA (Non-GAAP): $900,000 in Q4 2025, a $1.9 million improvement over Q4 2024.
Operating Expense (Non-GAAP): $22.3 million in Q4 2025, down from $19.8 million in Q4 2024.
Adjusted EBITDA (Non-GAAP) (Continuing Operations): $900,000 in Q4 2025, a $1.9 million improvement over Q4 2024.
Operating Expense (Non-GAAP) (Continuing Operations): $22.3 million in Q4 2025, down from $19.8 million in Q4 2024.
Adjusted EBITDA (Non-GAAP) (Continuing Operations) (Continuing Operations): $900,000 in Q4 2025, a $1.9 million improvement over Q4 2024.
Operating Expense (Non-GAAP) (Continuing Operations) (Continuing Operations) (Continuing Operations): $22.3 million in Q4 2025, down from $19.8 million in Q4 2024.
Adjusted EBITDA (Non-GAAP) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations): $900,000 in Q4 2025, a $1.9 million improvement over Q4 2024.
**Operating Expense (Non-GAAP) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations) (Continuing Operations

PiT-FT 2015

Invalid JSONshown as written

NeuroPace, Inc. - Q1 2015 Earnings Call

<|transcript>

Transcript of NeuroPace, Inc. - Q4 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q4 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q1 2015 Earnings Call

<|assistant|>

Transcript of NeuroPace, Inc. - Q

ChronoGPT 2015

Invalid JSONshown as written

###